A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis

National Taiwan University Hospital, Taipei

Chang Gung Medical Foundation-Linkou Branch, Taoyuan District

National Cheng-Kung University Hospital, Tainan City

Peking University First Hospital / The Department of Dermatology, Beijing

Peking University People's Hospital/Dermatology Department, Beijing

Dept. Of dermatology &STD, Beijing Friendship Hospital, Capital Medical University, Xicheng District

Beijing Hospital of the Ministry of Health/Department of Dermatology, Beijing

Peking Union Medical College Hospital/Department of Dermatology, Beijing

Department of Dermatology, The Second Affiliated Hospital of Dalian Medical University, Dalian

Huashan Hospital, Fudan University/Dermatology Department, Shanghai

Shanghai Changhai Hospital, Dermatology Department, Shanghai

Hospital of Skin Diseases, Chinese Academy of Medical Sciences, Nanjing

Tianjin Medical University General Hospital, Dermatological Department, Tianjin

The First Affiliated Hospital of College of Medicine, Zhejiang University/Dermatology and STD Dept, Hangzhou

The Second Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou

Sichuan Provincial People's Hospital, Chengdu

West China Hospital of Sichuan University, Chengdu

Dermatology Department, The First Affiliated Hospital, The Fourth Military Medical University, Xi’an

Seoul National University Hospital, Seoul

Department of Dermatology,Severance Hospital, Yonsei University Health System, Seoul

Samsung Medical Center, Seoul